Cardiac Pacemaker Development
心脏起搏器开发
基本信息
- 批准号:8585876
- 负责人:
- 金额:$ 37.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-12-02 至 2016-11-30
- 项目状态:已结题
- 来源:
- 关键词:Action PotentialsArrhythmiaArtificial cardiac pacemakerCardiacCardiac MyocytesCardiovascular systemCell Differentiation processCellsCharacteristicsCollaborationsDataDefectDevelopmentEmbryoEmbryonic DevelopmentExhibitsFutureGenerationsGenesGrowthHeartHeart DiseasesHumanImageIn Situ HybridizationIn VitroIon ChannelLateralLateral MesodermLeadLifeLocationMapsMediatingMesodermMesoderm CellMolecularMonitorMorbidity - disease rateOpticsPacemakersPathway interactionsPatternPhysiologicalPopulationPrevalenceProductionProtocols documentationRNAResearchReverse Transcriptase Polymerase Chain ReactionRoleSignal TransductionSinoatrial NodeSiteSpecific qualifier valueStagingTechniquesTestingTherapeuticTimeTissue EngineeringTissuesTubeViralabstractingbasecardiogenesiscell fate specificationcell typeeffective therapyembryo tissuein vivoion channel blockermortalitynodal myocytenovelprecursor cellrepairedserial analysis of gene expression
项目摘要
Project Summary/Abstract
Cardiac pacemaker cells of the Sinoatrial Node are essential for producing rhythmic heartbeats. Despite the
importance of this specialized cardiac cell type, little is known about their ontogeny or mechanisms of
specification and differentiation.
Our preliminary data show that although the primary heart tube initially displays rhythmic beating, the cells
pacing it do not differentiate into the Sinoatrial Node. Instead, pacemaker precursors arise from the mesoderm
posterior to the known cardiogenic field and take over the pacing function during heart-looping. Surprisingly,
the pacemaker precursor mesoderm can differentiate in culture without any other surrounding embryonic
tissues. They display sustained rhythmic beat rates, and sensitivity to pacemaker cell specific ion channel
blockers. Furthermore, they have the ability to pace other cardiomyocyte populations. Our global RNA profiling
has identified a unique set of Wnt-related genes expressed in pacemaker precursors.
These somewhat surprising findings lead to three central hypotheses: (1) the pacemaker precursors arise from
a specific mesoderm population separate from the heart field; (2) pacemaker cell fate is induced prior to heart
tube formation; and (3) Wnt-related signaling, which is inhibitory to the heart field, acts as a promoting signal
during pacemaker cell specification. We will test these hypotheses experimentally.
This proposal will provide the first basis for identifying the embryonic origin of pacemaker precursors (Aim 1),
the ability of a specific mesoderm subpopulations to enter the pacemaker cell fate (Aim 2), and novel molecular
mechanisms that specify and direct the differentiation this important cell type during a brief temporal window
and at a defined site in the embryo (Aim 3).
项目总结/摘要
窦房结的心脏起搏细胞对于产生节律性心跳是必不可少的。尽管
这种特殊的心脏细胞类型的重要性,很少有人知道他们的个体发育或机制,
规格和差异化。
我们的初步数据显示,虽然初级心管最初显示有节奏的跳动,
起搏它不分化成窦房结。相反,起搏器前体来自中胚层,
在已知的心电场之后,并在心脏循环期间接管起搏功能。令人惊奇的是,
起搏器前体中胚层可以在没有任何其他周围胚胎的情况下在培养中分化,
组织中它们表现出持续的节律性搏动率,并对起搏细胞特异性离子通道敏感
阻滞剂。此外,它们还具有调节其他心肌细胞群的能力。我们的全球RNA分析
已经确定了一组独特的Wnt相关基因在起搏器前体中表达。
这些有些令人惊讶的发现导致了三个中心假设:(1)起搏器前体来自于
与心脏区域分离的特定中胚层群体;(2)起搏细胞命运在心脏区域之前被诱导。
管形成;和(3)Wnt相关信号,其对心脏场是抑制性的,充当促进信号
在起搏器细胞规格。我们将用实验来检验这些假设。
这一建议将为确定起搏器前体的胚胎起源提供第一个基础(目标1),
特定中胚层亚群进入起搏细胞命运的能力(Aim 2),以及新的分子生物学。
在短暂的时间窗口内指定和指导这种重要细胞类型分化的机制
在胚胎中的一个确定的位置(目标3)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Takashi Mikawa其他文献
Takashi Mikawa的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Takashi Mikawa', 18)}}的其他基金
Development of Vascular Smooth Muscle Stem Cell Niche
血管平滑肌干细胞生态位的开发
- 批准号:
10198034 - 财政年份:2019
- 资助金额:
$ 37.85万 - 项目类别:
Development of Vascular Smooth Muscle Stem Cell Niche
血管平滑肌干细胞生态位的开发
- 批准号:
10447576 - 财政年份:2019
- 资助金额:
$ 37.85万 - 项目类别:
相似海外基金
DEVELOPING A HUMAN STEM CELL-DERIVED HEART MODEL TO CHARACTERIZE A NOVEL ARRHYTHMIA SYNDROME
开发人类干细胞衍生的心脏模型来表征新型心律失常综合征
- 批准号:
495592 - 财政年份:2023
- 资助金额:
$ 37.85万 - 项目类别:
Preliminary Study to Establish Heavy Ion Ablation Therapy for Lethal Ventricular Arrhythmia
重离子消融治疗致死性室性心律失常的初步研究
- 批准号:
23K14885 - 财政年份:2023
- 资助金额:
$ 37.85万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Arrhythmia Mechanisms Modulated by Intercalated Disc Extracellular Nanodomains
闰盘细胞外纳米结构域调节心律失常的机制
- 批准号:
10668025 - 财政年份:2023
- 资助金额:
$ 37.85万 - 项目类别:
The role of inflammation in the pathogenesis of atrial fibrillation: Implications for atrial remodeling pathophysiology and for early atrial arrhythmia recurrences following radiofrequency ablation and pulsed field ablation
炎症在心房颤动发病机制中的作用:对心房重塑病理生理学以及射频消融和脉冲场消融后早期房性心律失常复发的影响
- 批准号:
514892030 - 财政年份:2023
- 资助金额:
$ 37.85万 - 项目类别:
WBP Fellowship
Development of a next-generation telemonitoring system for prognostic prediction of the onset of heart failure and arrhythmia
开发下一代远程监测系统,用于心力衰竭和心律失常发作的预后预测
- 批准号:
23K09597 - 财政年份:2023
- 资助金额:
$ 37.85万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improved arrhythmia ablation via MR-guided robotic catheterization and multimodal clinician feedback
通过 MR 引导的机器人导管插入术和多模式临床医生反馈改善心律失常消融
- 批准号:
10638497 - 财政年份:2023
- 资助金额:
$ 37.85万 - 项目类别:
Prototype development and validation of soft robotic sensor arrays for mapping cardiac arrhythmia
用于绘制心律失常的软机器人传感器阵列的原型开发和验证
- 批准号:
10722857 - 财政年份:2023
- 资助金额:
$ 37.85万 - 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
- 批准号:
10733915 - 财政年份:2023
- 资助金额:
$ 37.85万 - 项目类别:
A novel regulator of Ca2+ homeostasis and arrhythmia susceptibility
Ca2 稳态和心律失常易感性的新型调节剂
- 批准号:
10724935 - 财政年份:2023
- 资助金额:
$ 37.85万 - 项目类别:
Novel Stellate Ganglia Chemo-ablation Approach to Treat Cardiac Arrhythmia and Cardiac Remodeling in Heart Failure
新型星状神经节化疗消融方法治疗心律失常和心力衰竭心脏重塑
- 批准号:
10727929 - 财政年份:2023
- 资助金额:
$ 37.85万 - 项目类别:














{{item.name}}会员




